Danaher Balance Sheet Health
Financial Health criteria checks 5/6
Danaher has a total shareholder equity of $53.5B and total debt of $18.4B, which brings its debt-to-equity ratio to 34.4%. Its total assets and total liabilities are $84.5B and $31.0B respectively. Danaher's EBIT is $5.4B making its interest coverage ratio -316.5. It has cash and short-term investments of $5.9B.
Key information
34.4%
Debt to equity ratio
US$18.40b
Debt
| Interest coverage ratio | -316.5x |
| Cash | US$5.86b |
| Equity | US$53.49b |
| Total liabilities | US$31.00b |
| Total assets | US$84.49b |
Recent financial health updates
Is Danaher (NYSE:DHR) Using Too Much Debt?
Jan 12
These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well
Jul 13Is Danaher (NYSE:DHR) Using Too Much Debt?
Mar 02Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?
Nov 20Recent updates
Danaher: All In On Life Sciences, And Market Update
Mar 27Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?
Mar 11Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings
Feb 10Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term
Jan 30Is Danaher (NYSE:DHR) Using Too Much Debt?
Jan 12My Top 2024 Stock Pick: Danaher
Dec 27Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles
Nov 26RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing
Nov 19Why Danaher Is One Of My Favorite Long-Term Investments
Oct 26Danaher: Short-Term Headwinds, But Long-Term Tailwinds
Oct 17Should Danaher Investors Sell New Veralto Shares?
Oct 02Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price
Sep 30Danaher: A Lost Year
Aug 30Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens
Aug 02Danaher: A Compounding Icon At A Fair Price
Jul 25These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well
Jul 13Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)
Jun 28Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump
Jun 22At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?
Jun 15Danaher: A Great Chance To Buy This Long-Term Compounder
May 23With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case
Apr 26Estimating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)
Mar 28Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?
Mar 15Is Danaher (NYSE:DHR) Using Too Much Debt?
Mar 02Danaher ups dividend by 8% to $0.27
Feb 22Danaher Q4 2022 Earnings Preview
Jan 23Does Danaher (NYSE:DHR) Deserve A Spot On Your Watchlist?
Jan 16We Have A Winner! Revisiting Danaher And Thermo Fisher
Jan 11Danaher downgraded to neutral at Credit Suisse on exposure to inventory reductions
Jan 05A Look At The Fair Value Of Danaher Corporation (NYSE:DHR)
Dec 18Danaher: A Great Business - The Price Where I Would Buy
Dec 14Danaher declares $0.25 dividend
Dec 06When Should You Buy Danaher Corporation (NYSE:DHR)?
Dec 04Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?
Nov 20Danaher Q3 2022 Earnings Preview
Oct 19Financial Position Analysis
Short Term Liabilities: DHR's short term assets ($13.9B) exceed its short term liabilities ($8.3B).
Long Term Liabilities: DHR's short term assets ($13.9B) do not cover its long term liabilities ($22.7B).
Debt to Equity History and Analysis
Debt Level: DHR's net debt to equity ratio (23.4%) is considered satisfactory.
Reducing Debt: DHR's debt to equity ratio has reduced from 34.5% to 34.4% over the past 5 years.
Debt Coverage: DHR's debt is well covered by operating cash flow (38.9%).
Interest Coverage: DHR earns more interest than it pays, so coverage of interest payments is not a concern.